Prevalence of Metabolic Syndrome in Moderate to Severe Chronic Plaque Psoriatic Patients in Phra Nakhon Si Ayutthaya Hospital

Authors

  • ภัฑรา เรือนงาม Department of Medicine, Phra Nakhon Si Ayutthaya Hospital, Phra Nakhon Si Ayutthaya Province.

Keywords:

Moderate to severe chronic plaque psoriasis, metabolic syndrome, prevalence

Abstract

     Psoriasis is a chronic inflammatory dermatitis found commonly in medical practices. Studies found the psoriasis association with metabolic syndrome which lead to cardiovascular disease. The study aimed to examine the prevalence of metabolic syndrome in moderate to severe chronic plaque psoriatic patients at dermatologic outpatient clinic of Phra Nakhon Si Ayutthaya hospital during June to December 2018. A total of 32 of moderate to severe chronic plaque psoriatic patients (19 males, 59.4% and 13 females, 40.6%), 20 were found with metabolic syndrome (12 males, 8 females). The prevalence of metabolic syndrome was 62.5% with 63.2% for male group and 61.5% for female group. Compared to moderate to severe chronic plaque psoriatic patients with regular metabolic parameters, those with abnormal waist line, blood sugar, blood pressure and triglyceride were diagnosed metabolic syndrome with odds ratio 209, 13.4, 11.7 and 9.3 respectively in statistically significant. Patients with abnormal high-density lipoprotein cholesterol and gender had no significant association with metabolic syndrome.

References

1. Gudjonsson JE, Elder JT. Psoriasis. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Klaus Wolff. Fitzpatrick’s Dermatology in General medicine. 8th ed. New York: McGraw-Hill professional. 2012;197-231.
2. Aekplakorn W, Kessomboon P, Sangthong R, Chariyalertsak S, Putwatana P, Inthawong R. et al. Urban and rural variation in clustering of metabolic syndrome components in the Thai population: results from the fourth National Health Examination Survey
2009. BMC Public Health 2011;11:854-61.
3. Gottlieb AB, Dann F, Menter A. Psoriasis and the metabolic syndrome. J Drugs Dermatol 2008;7:563-72.
4. Takahashi H, Iizuka H. Psoriasis and metabolic syndrome. J Dermatol 2012;39:212-8.
5. Takahashi H, Takahashi I, Honma M, Ishida-Yamamoto A, Iizuka H. Prevalence of metabolic syndrome in Japanese psoriasis patients. J Dermatol Sci 2010;57:143-4.
6. Armstrong AW, Harskamp CT, Armstrong EJ. Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies. J Am Acad Dermatol 2013;68:654-62.
7. Rodríguez-Zúñiga MJM, García-Perdomo HA. J Am Acad Dermatol 2017;77:657-66.
8. Kokpol C, Aekplakorn W, Rajatanavin N. Prevalence and characteristics of metabolic syndrome in South-East Asian psoriatic patients: a case-control study. J Dermatol 2014;41:898-902.
9. Gisondi P, Fostini AC, Fossà I, Girolomoni G, Targher G. Psoriasis and the metabolic syndrome. Clin Dermatol 2018;36:21-8.

Downloads

Published

2019-09-23

How to Cite

1.
เรือนงาม ภ. Prevalence of Metabolic Syndrome in Moderate to Severe Chronic Plaque Psoriatic Patients in Phra Nakhon Si Ayutthaya Hospital. JPMAT [Internet]. 2019 Sep. 23 [cited 2024 Nov. 24];9(2):141-9. Available from: https://he01.tci-thaijo.org/index.php/JPMAT/article/view/217590

Issue

Section

Original Article